The antitumor compound triazoloacridinone C-1305 inhibits FLT3 kinase activity and potentiates apoptosis in mutant FLT3-ITD leukemia cells
Crossref DOI link: https://doi.org/10.1038/aps.2014.142
Published Online: 2015-02-02
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Augustin, Ewa
Skwarska, Anna
Weryszko, Anna
Pelikant, Iwona
Sankowska, Ewa
Borowa-Mazgaj, Barbara
Text and Data Mining valid from 2015-02-02
Article History
Received: 9 May 2014
Accepted: 7 December 2014
First Online: 2 February 2015